NEWS – Ovarian Cancer 101
NEWS 2017-09-21T19:47:34+00:00
  • New Sensor Detects Ovarian Cancer in Noninvasive Manner in Mice, Study Shows
    by admin on April 23, 2018 at 6:56 pm

    This post was originally published on this site A new sensor, found capable of identifying ovarian cancer in a noninvasive way in mice, may have the potential to detect early-stage ovarian cancer in the future, and possibly monitor for cancer recurrence. The technology is based on the detection of human epididymis protein 4 (HE4), one of […] The post New Sensor Detects Ovarian Cancer in Noninvasive Manner in Mice, Study Shows appeared first on BioNewsFeeds. […]

  • Rivkin Center Awards $1.18 Million in Ovarian Cancer Research Grants
    by Carolina Henriques on April 20, 2018 at 12:00 pm

    This post was originally published on this site The nonprofit Rivkin Center for Ovarian Cancer recently awarded $1.185 million in research grants for 2018 – a 10 percent increase from 2017 – to fund projects that will study ovarian cancer. The grants were awarded to researchers from the United States, Italy, Australia and Israel, whose […] The post Rivkin Center Awards $1.18 Million in Ovarian Cancer Research Grants appeared first on BioNewsFeeds. […]

  • Personalized Vaccine for Advanced Ovarian Cancer Offers Promising Results in Pilot Study
    by admin on April 18, 2018 at 1:09 pm

    This post was originally published on this site A personalized vaccine targeted to a patient’s own tumor cells yielded promising results in patients with recurrent advanced ovarian cancer, a Phase 1 pilot trial shows. The vaccine was safe, capable of triggering a broad anti-tumor immune response, and significantly delayed disease progression in patients responding to […] The post Personalized Vaccine for Advanced Ovarian Cancer Offers Promising Results in Pilot Study appeared first on BioNewsFeeds. […]

  • Approved Blood Cancer Inhibitors May Be Effective Therapy for Ovarian Tumors, Study Finds
    by admin on April 16, 2018 at 11:11 pm

    This post was originally published on this site A class of inhibitors approved for the treatment of several blood cancers may be an effective therapy for ovarian cancer patients who have mutations in the ARID1A gene, according to researchers. The study, “Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer,” was published in the journal Cell Reports. Cancer […] The post Approved Blood Cancer Inhibitors May Be Effective Therapy for Ovarian Tumors, Study Finds appeared first on BioNewsFeeds. […]

  • Bright Pink Creates Online Courses on Preventing Ovarian and Breast Cancer
    by Carolina Henriques on April 13, 2018 at 3:54 pm

    This post was originally published on this site The U.S. women’s health organization Bright Pink has created online courses designed to improve care providers’ ability to manage their patients’ risk of developing ovarian and breast cancer. The courses consist of interactive exercises drawn from real cases. The goal is to give participants new skills in working collaboratively […] The post Bright Pink Creates Online Courses on Preventing Ovarian and Breast Cancer appeared first on BioNewsFeeds. […]

  • First Patient Treated in Test of OLT38, a Dye to Detect Ovarian Cancer Tissue During Surgery
    by admin on April 11, 2018 at 5:31 pm

    This post was originally published on this site A Phase 3 clinical trial testing a special dye that “lights up” ovarian tumor tissue during surgery has treated its first participant, On Target Laboratories announced. The dye, called OTL38, is designed to make removal of cancerous tissue more complete and increase patients’ survival. “Treating our first patient […] The post First Patient Treated in Test of OLT38, a Dye to Detect Ovarian Cancer Tissue During Surgery appeared first on BioNewsFeeds. […]

  • Zejula-Keytruda Combo Shows Promise in Certain Ovarian Cancer Patients in Clinical Trial
    by admin on April 9, 2018 at 9:32 pm

    This post was originally published on this site A combination of Zejula (niraparib) and Keytruda (pembrolizumab) reduced tumor size in one out of four difficult-to-treat ovarian cancer patients, Tesaro‘s Phase 1/2 trial revealed. The 25% response rate seen in the trial — called TOPACIO (NCT02657889) — was superior to that seen in historical controls treated with […] The post Zejula-Keytruda Combo Shows Promise in Certain Ovarian Cancer Patients in Clinical Trial appeared first on BioNewsFeeds. […]

  • Bedside Chart Improves Cancer Patients’ Pain Management, Study Shows
    by admin on April 6, 2018 at 4:58 pm

    This post was originally published on this site A simple bedside chart for assessing and managing pain reduced hospitalized cancer patients’ pain without increasing their use of opioids, a large British study showed. Its findings suggested that systematic pain assessment and management should be part of  cancer care. A breakdown of the types of cancer […] The post Bedside Chart Improves Cancer Patients’ Pain Management, Study Shows appeared first on BioNewsFeeds. […]

  • FATE-NK100 Shows Signs of Tumor Reduction in First Ovarian Cancer Patients in Phase 1 Trial
    by admin on April 4, 2018 at 6:09 pm

    This post was originally published on this site FATE-NK100, a natural killer cell immunotherapy, induced stable disease in one of the first two heavily treated ovarian cancer patients in a Phase 1 trial. No dose-limiting toxicities have been reported so far, Fate Therapeutics announced. The findings were recently revealed during the oral presentation, “Novel strategies to activate […] The post FATE-NK100 Shows Signs of Tumor Reduction in First Ovarian Cancer Patients in Phase 1 Trial appeared first on BioNewsFeeds. […]

  • Personalized Immunotherapy May Be Effective Ovarian Cancer Treatment, Study Finds
    by admin on April 2, 2018 at 4:58 pm

    This post was originally published on this site A new method that identifies and expands T-cells with high tumor-killing activity is a promising approach against ovarian cancer, a study shows. Findings could be used to develop a personalized, cell-based immunotherapy that effectively treats ovarian cancer, which has proven resistant to current immunotherapies. Using this method, researchers […] The post Personalized Immunotherapy May Be Effective Ovarian Cancer Treatment, Study Finds appeared first on BioNewsFeeds. […]

0